Passage BIO is a company focusing on genetic medicine designed to treat rare monogenetic diseases of central nervous system. PBGM01 by Passage is a product intended for patients that suffer from infantile gangliodosis, a serious disease that progressively destroys neurons in medulla and cerebrum. The company is going to request a permission for testing on humans from the U.S. Food and Drug Administration (FDA) in the first half of 2020, with the 1/2 test phase due to begin in the second half. The Pennsylvania University is one of the company's strategic research partners.
Learn more about previous IPOs
Our clients participated in the following IPOs:
IPO (Initial Public Offering) – the initial offering of a company shares. In the whole world people actively discuss IPOs’ investment opportunities: on average, the returns of IPO exceed the return of investments in ordinary securities.
The initial public offering of shares on a stock exchange is aimed at attracting additional funds for various needs of an issuing company. An IPO is a complex and multi-level process organized by special financial companies (investment banks and underwriters). Freedom Finance offers all its customers the opportunity to participate in such public offerings.
In order to minimize risks, our professional analysts carry out detailed research of companies and businesses that go public for the first time.
The successful results of many IPOs confirm the effectiveness of this investment tool. The American company called EventBrite, which provides management and ticketing services, was chosen by our experts as a good investment option in September 2018. Contrary to the low initial assessment of third-party experts, the price for company's shares rose by 58.7% in the opening exchange trades and reached $ 36.50. You can take a look at the results of some other successful IPOs here: Dropbox, Tenable, Elastik, Arlo Technologies, Anaplan.
Freedom Finance offers its customers to make additional money by investing in securities. The opportunities of IPOs are confirmed by impressive results: in the past 5 years, initial public offerings attracted more than $7 trillion. The average annual rate of return from an IPO investment with Freedom Finance is more than 35%. Our analysts will help you choose the most promising offers on the financial market and will make sure you invest in successful projects!